A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
I8F-MC-GPHU - ClinicalTrials.gov - NCT04407234
The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/very overweight participants. Participants include those without diabetes and those with type 2 diabetes.
Trial Summary
Age Range
18 - 65 yearsConditions the trial is for
Type 2 Diabetes, ObesityWhat the trial is testing?
Acetaminophen, TirzepatideCould I receive a Placebo?
NoEnrollment Goal
36Trial Dates
Sep 15, 2020 - Jan 7, 2021How long will I be in the trial?
Participation will last about 13 weeks, including screening.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo